aXichem Overview

  • Founded
  • 1999
Founded
  • Status
  • Public
  • Employees
  • 6
Employees
  • Stock Symbol
  • AXIC A
Stock Symbol
  • Share Price
  • $1.53
  • (As of Tuesday Closing)

aXichem General Information

Description

aXichem AB develops and delivers nature-identical ingredients of the highest purity. The company offers axiphen-feed used in the breeding of chicken and pigs, Bio-repellents used to repel unwanted biological organisms from installations or areas and aXivite an alternative to capsaicin.

Contact Information

Website
www.axichem.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Specialty Chemicals
Stock Exchange
STO
Primary Office
  • Södergatan 26
  • 211 34 Malmö
  • Sweden
+46 046-780 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

aXichem Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.53 $1.51 $1.31 - $3.95 $25M 16.5M 11.5K -$0.10

aXichem Financials Summary

In Thousands,
USD 		TTM 30-Sep-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 49,154 93,251 140,168 121,519
Revenue 408 133 36 40
EBITDA (1,309) (1,223) (1,116) (965)
Net Income (1,590) (1,466) (1,326) (1,141)
Total Assets 7,315 6,796 7,385 4,276
Total Debt 0 0 0 827
Public Fundamental Data provided by Morningstar, Inc. disclaimer

aXichem Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore aXichem‘s full profile, request access.

Request a free trial

aXichem Patents

  • 26

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 2

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

aXichem Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2018351640-A1 Synthetic capsaicin analogues as bioenhancers Pending 20-Oct-2017 000000000
US-20200253902-A1 Synthetic capsaicin analogues as bioenhancers Pending 20-Oct-2017 0000000000
JP-2021500402-A Synthetic capsaicin analog as a bioenhancer Pending 20-Oct-2017 0000000000
EP-3697402-A1 Synthetic capsaicin analogues as bioenhancers Pending 20-Oct-2017 000000000
JP-2018530351-A Avian and in particular poultry feeds containing synthetic capsaicinoid derivatives, and such feeds for the prophylactic use or treatment of salmonella infections Granted 09-Oct-2015 A23K20/111
To view aXichem’s complete patent history, request access »

aXichem Executive Team (3)

Name Title Board Seat Contact Info
Torsten Helsing Chief Executive Officer & Board Member
Erik Lager Ph.D Chief Technical Officer
Lucas Altepost Chief Sales and Marketing Officer & Deputy Managing Director
To view aXichem’s complete executive team members history, request access »

aXichem Board Members (1)

Name Representing Role Since
0000000 0000000 aXichem Chief Executive Officer & Board Member 000 0000
To view aXichem’s complete board members history, request access »

aXichem Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial